From zero to one: Recent advances in the pathogenesis, diagnosis, and treatment of vitiligo

3Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Vitiligo is the most common acquired pigmentary disorder and can have profound negative psychosocial impacts on patients. The disease course of vitiligo is often unpredictable, and diagnosis and treatment of vitiligo remain a challenging dermatological task. In this review, we touch on new advances in understanding vitiligo pathogenesis; discuss emerging biomarkers that may aid physicians in assessing vitiligo disease activity and severity, and summarize prospective targeted therapies in treating vitiligo. A brief outline dedicated to the impact of the coronavirus disease 2019 pandemic on vitiligo patients is also provided. We hope that readers may acquire a more comprehensive understanding of vitiligo and gain insights into new diagnostic tools and therapeutic options for vitiligo.

Author supplied keywords

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Shen, P. C., Tsai, T. F., Lai, Y. J., Liu, T. L., & Ng, C. Y. (2023, July 1). From zero to one: Recent advances in the pathogenesis, diagnosis, and treatment of vitiligo. Dermatologica Sinica. Wolters Kluwer Medknow Publications. https://doi.org/10.4103/ds.DS-D-23-00054

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 1

100%

Readers' Discipline

Tooltip

Medicine and Dentistry 1

100%

Save time finding and organizing research with Mendeley

Sign up for free